Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Waukegan, Illinois 60085


Purpose:

The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.


Criteria:

Inclusion Criteria: - Adult Male or Female 18-55 yrs. - Subject has provided written consent. - Subject is in general good health. - If female, subject is postmenopausal. - If female, subject is not pregnant and is not breast-feeding. - Subject must use birth control methods or be surgically sterile. Exclusion Criteria: - Subject is HAV-IgM, HBsAg or HIV Ab positive. - Positive screen for drugs of abuse, alcohol, or smoking. - Cannot be on any medication, including over the counter drugs. - Cannot have previous history of alcohol or drug abuse. - Cannot have history of any major diseases or disorders.


NCT ID:

NCT00743470


Primary Contact:

Study Director
Angela Nilius, MD
Abbott


Backup Contact:

N/A


Location Contact:

Waukegan, Illinois 60085
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.